Iovance Biotherapeutics share price logo

Iovance Biotherapeutics

NASDAQ: IOVA

Mid Cap

$8.01

-0.47

(-5.60%)

as on

Iovance Biotherapeutics Stock Performance

as on November 3, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $7.66
    $8.56
    downward going graph

    4.37%

    Downside

    6.87%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.76
    $15.37
    downward going graph

    78.03%

    Downside

    91.89%

    Upside

    downward going graph

Iovance Biotherapeutics share price movements today

Previous Close
$8.48
Open
$8.53
Volume
20.7M
Market Cap
$3.8B
Day's Low - High
$7.66 - $8.56
52 Week Low - High
$1.76 - $15.37

Iovance Biotherapeutics Historical Returns

1 Month Return
-40.34 %
3 Month Return
+ 108.35 %
1 Year Return
+ 330.46 %
3 Year Return
+ 118.56 %
5 Year Return
-65.58 %

Iovance Biotherapeutics Stock Fundamentals & Key Indicators

Check Iovance Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.8B

EPS (TTM)

-0.73

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-11.62

Industry PE ratio

-7.37

PEG Ratio

-0.21

EBITDA

-251.2M

Revenue (TTM)

325.0M

Profit Margin

48.40%

Return On Equity TTM

-40.51%

Iovance Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iovance Biotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$3.8B-65.58%-11.6248.40%0.00%
Neutral$88.5B-36.40%-27.78-12.57%0.00%
StrongBuy$141.7B208.09%32.2786.04%0.00%
Buy$95.5B45.26%19.7685.77%0.40%

Stock Returns calculator for Iovance Biotherapeutics Stock including INR - Dollar returns

The Iovance Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iovance Biotherapeutics investment value today

Current value as on today

₹4,34,904

Returns

₹3,34,904

(+334.9%)

Returns from Iovance Biotherapeutics Stock

₹3,06,599 (+306.6%)

Dollar Impact

₹28,305 (+28.31%)

Analyst Recommendation on Iovance Biotherapeutics Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Iovance Biotherapeutics. Average target price of $14.2

Iovance Biotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Iovance Biotherapeutics.

What analysts predicted

43.59%UPSIDE

Target Price

$14.2

Current Price

$8.01

Analyzed by

6 Analysts

High

$20

Target

$14.20

Low

$7

Iovance Biotherapeutics target price $14.2, a slight upside of 43.59% compared to current price of $8.01. According to 6 analysts rating.

Indian Investors' Interest in Iovance Biotherapeutics Stock

Investment in Iovance Biotherapeutics Shares on INDmoney has grown by 177.89% in the last 30 days, indicating increased investment activity.

Time period: to

Change:177.89% versus previous 30 day period

Search interest for Iovance Biotherapeutics Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:4% versus previous 30 day period

Iovance Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
31
58
73
49
59
67
86
71
99
Gross Profit
-6
0
18
28
6
11
28
43
28
55
Operating Income
-117
-101
-89
-86
-121
-113
-89
-73
-81
-51
EBITDA
-104
-87
-77
-65
-110
-101
-78
-60
-70
-41
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
9
10
11
11
10
12
11
12
10
10
Income Before Tax
-114
-98
-85
-77
-118
-109
-93
-71
-79
-48
Income Tax Expense
-1
-1
-1
1
-1
1
-2
0
0
-1
Net Income
-112
-97
-83
-78
-116
-111
-91
-71
-79
-47
Net Profit Margin
-915.52%
-0.84%
31.99%
38.20%
-0.85%
18.47%
42.96%
50.32%
40.50%
56.10%

Iovance Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
1
164
263
Gross Profit
0
0
-8
-
-
-
-9
40
90
Operating Income
-92
-128
-206
-261
-342
-398
-460
-395
-398
EBITDA
-91
-122
-189
-260
-328
-371
-414
-331
-350
Interest Expense
-
-
-
-
-
2
-
-
-
Depreciation
0
0
8
1
13
21
33
43
47
Income Before Tax
-92
-123
-197
-259
-342
-395
-447
-375
-393
Income Tax Expense
-
-
-
-
-
-
-3
-2
-2
Net Income
-92
-123
-197
-259
-342
-395
-444
-372
-390
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-804.54%
24.43%
34.28%

Iovance Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-112
-97
-83
-78
-116
-111
-91
-71
-79
-47
Operating Cash Flow
-122
-98
-58
-73
-103
-67
-78
-52
-72
-60
Investing Cash Flow
-111
40
-48
23
15
13
17
0
11
-74
Financing Cash Flow
193
152
41
2
143
13
88
56
94
49
Change in Cash
-40
94
-64
-48
55
-39
25
4
-157
-190

Iovance Biotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-92
-123
-197
-259
-342
-395
-444
-372
-390
Operating Cash Flow
-78
-101
-158
-205
-227
-292
-361
-352
-302
Investing Cash Flow
58
-386
90
-317
0
256
-155
-96
47
Financing Cash Flow
58
424
6
576
239
190
462
390
300
Change in Cash
38
-63
-62
53
11
153
-56
-59
47

Global Institutional Holdings in Iovance Biotherapeutics

Check out the Institutions with significant holdings in Iovance Biotherapeutics.

Funds
Holdings
Vanguard
6.64%
VANGUARD INDEX FUNDS
5.68%
iShares
4.62%
SPDR
3.09%
Fidelity Salem Street Trust
1.10%

Iovance Biotherapeutics News & Key Events

  • img

    Today's Timeline - 02 November

    Mon, 11:41 AM

    -

    IOVA plunged 43% in October, underperforming the SPDR S&P Biotech ETF amid competitive pressures.

    Mon, 09:49 PM

    -

    Iovance expected to surpass earnings expectations with narrower loss and higher revenues in Q3 2026 results.

Insights on Iovance Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, IOVA stock has moved up by 108.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 211.3% return, outperforming this stock by 92.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 385.8%

About Iovance Biotherapeutics

Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary experimental compound, lifileucel, for individuals with advanced melanoma. Another trial, C-145-04, is assessing lifileucel's potential for treating cervical cancer that is recurrent, metastatic, or persistent. Additionally, investigational product LN-145 is undergoing evaluation in trial C-145-03 for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. maintains strategic alliances and licensing arrangements with several distinguished entities, including H. Lee Moffitt Cancer Center, M.D. Anderson Cancer Center, Ohio State University, the Centre hospitalier de l'Université de Montreal, Cellectis S.A., and Novartis Pharma AG. Established in 2007, the company was previously known as Lion Biotechnologies, Inc. It adopted its current name, Iovance Biotherapeutics, Inc., in June 2017. Its corporate offices are located in San Carlos, California.
OrganisationIovance Biotherapeutics
Headquarters825 Industrial Road, San Carlos, CA, 94070, US
IndustryBiotechnology
CEOFrederick G. Vogt

Key Management of Iovance Biotherapeutics

Name

Title

Ms. Sara Pellegrino

Senior Vice President of Investor Relations & Corporate Communications

Mr. Howard B. Johnson M.B.A.

Chief Business Officer

Mr. Kevin Smyth

Executive Vice President of Quality

Dr. Frederick G. Vogt Esq., J.D., Ph.D.

Interim CEO, President, General Counsel, Corporate Secretary & Director

Dr. Igor P. Bilinsky Ph.D.

Chief Operating Officer

Mr. Daniel G. Kirby

Chief Commercial Officer

Dr. Brian Gastman M.D.

Executive Vice President of Translational Medicine & Research

Ms. Corleen M. Roche

Chief Financial Officer

Dr. Raj K. Puri M.D., Ph.D.

Chief Regulatory Officer

Ms. Tracy Winton

Executive Vice President of Human Resources

FAQs

What is Iovance Biotherapeutics share price today?

Iovance Biotherapeutics share price today is $8.01 as on at the close of the market. Iovance Biotherapeutics share today touched a day high of $8.56 and a low of $7.66.

What is the 52 week high and 52 week low for Iovance Biotherapeutics share?

Iovance Biotherapeutics share touched a 52 week high of $15.37 on and a 52 week low of $1.76 on . Iovance Biotherapeutics stock price today i.e. is closed at $8.01,which is 47.89% down from its 52 week high and 355.11% up from its 52 week low.

What is Iovance Biotherapeutics's market capitalisation today?

Iovance Biotherapeutics market capitalisation is $0.00T as on .

How to invest in Iovance Biotherapeutics Stock (IOVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Iovance Biotherapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Iovance Biotherapeutics Stock (IOVA) from India?

Indian investors can start investing in Iovance Biotherapeutics (IOVA) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Iovance Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Iovance Biotherapeutics share’s latest price of $8.01 as on November 3, 2026 at 2:29 am IST, you will get 1.2484 shares of Iovance Biotherapeutics. Learn more about fractional shares .

What are the returns that Iovance Biotherapeutics has given to Indian investors in the last 5 years?

Iovance Biotherapeutics stock has given -65.58% share price returns and 27.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?